Healthcare & Life Sciences

HAS Healthcare Advanced Synthesis SA

acquiredacquired
acquired
Stage
1
Investors

About

HAS Healthcare Advanced Synthesis SA is a Swiss-based contract development and manufacturing organization (CDMO) that develops and produces active pharmaceutical ingredients (APIs), highly potent APIs (HPAPIs), anticancer compounds, and antibody drug conjugates for pharmaceutical and biotech companies.

Explore HAS Healthcare Advanced Synthesis SA's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.